Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Short-term Investments (2017 - 2025)

Q32 Bio (QTTB) has 8 years of Short-term Investments data on record, last reported at $10.0 million in Q2 2024.

  • For Q2 2024, Short-term Investments fell 80.14% year-over-year to $10.0 million; the TTM value through Jun 2024 reached $10.0 million, down 80.14%, while the annual FY2022 figure was $141.0 million, 196.98% up from the prior year.
  • Short-term Investments reached $10.0 million in Q2 2024 per QTTB's latest filing, down from $19.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $157.9 million in Q3 2022 and bottomed at $8.0 million in Q1 2022.
  • Average Short-term Investments over 5 years is $71.1 million, with a median of $62.2 million recorded in 2023.
  • Peak YoY movement for Short-term Investments: soared 1282.31% in 2023, then plummeted 82.09% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $91.6 million in 2020, then tumbled by 48.13% to $47.5 million in 2021, then skyrocketed by 196.98% to $141.0 million in 2022, then plummeted by 47.4% to $74.2 million in 2023, then crashed by 86.54% to $10.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $10.0 million in Q2 2024, $19.8 million in Q1 2024, and $74.2 million in Q3 2023.